CAPR- Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. (CAPR) has 11 insiders with recent SEC Form 4 filings, including 21 buys and 0 sells. CAPR is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 116.1K | $3.07M | -900 | |
| Other | 80.0K | $2.12M | - | |
| Dir | 50.0K | $1.32M | - | |
| CEO | 50.0K | $1.32M | - | |
| VP | 30.5K | $807.7K | -900 |
Activity
Buys and sells only
Transactions
10 filings · page 3
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2016 | Marban Linda | Chief Executive Officer | Buy | 10,152 | $2.40 | $24,364.80 | +3.9% | |
| Mar 16, 2016 | Bergmann Anthony | Vice President Of Finance | Buy | 2,030 | $2.40 | $4,872.00 | New | |
| Mar 16, 2016 | Manzo Louis | Director | Buy | 100,000 | $2.40 | $240,000.00 | +352.3% | |
| Mar 16, 2016 | Grasmick Louis J | Director | Buy | 91,369 | $2.40 | $219,285.60 | +8.7% | |
| Mar 16, 2016 | Cedars Sinai Medical Center | 10% Owner | Buy | 416,666 | $2.40 | $999,998.40 | +19.2% | |
| Aug 20, 2015 | Grasmick Louis J | Director | Buy | 11,900 | $4.11 | $48,893.82 | +450.8% | |
| Aug 19, 2015 | Marban Linda | Chief Executive Officer | Buy | 18,400 | $4.36 | $80,228.00 | +0.3% | |
| Aug 19, 2015 | Marban Eduardo | 10% Owner | Buy | 18,400 | $4.36 | $80,228.00 | +0.3% | |
| Jan 21, 2015 | Kazam Joshua A | Director | Buy | 7,096 | $3.52 | $24,999.21 | +22.9% | |
| Jan 21, 2015 | St. John Edward A. | 10% Owner | Buy | 851,546 | $3.52 | $2,999,996.56 | New |